- 5101. Anaplastic Large Cell Lymphoma Stage II
- [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). - 2003 ( NCI )] (UMLS (NCI) C0854823) Anaplastic Large Cell Lymphoma T- and Null-Cell Types Stage II;
Stage II Anaplastic Large Cell Lymphoma;
=Neoplastic Process | - 5151. Anatomy, Comparative
- [The comparative study of animal structure with regard to homologous organs or parts. (Stedman, 25th ed) ( MSH )] (UMLS (NCI) C0002811) =Biomedical Occupation or Discipline
|
- 5102. Anaplastic Large Cell Lymphoma Stage III
- [Ann Arbor Classification. Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). - 2003 ( NCI )] (UMLS (NCI) C0854824) Anaplastic Large Cell Lymphoma T- and Null-Cell Types Stage III;
Stage III Anaplastic Large Cell Lymphoma;
=Neoplastic Process | - 5152. ANC1
- [Interacts with SNF5. Not required for DNA-dependent ATPase activity of SWI complex (10). Also part of TFIID and TFIIF complexes (10). Related to MLL translocation partners AF-9 and ENL. ( NCI )] (UMLS (NCI) C1335887) SWP29;
TAF30;
TAFII3;
Tfg3;
TFG3/TAF30/ANC1;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 5103. Anaplastic Large Cell Lymphoma Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow or nodular involvement of the lung(s). - 2003 ( NCI )] (UMLS (NCI) C0854825) Anaplastic Large Cell Lymphoma T- and Null-Cell Types Stage IV;
Stage IV Anaplastic Large Cell Lymphoma;
=Neoplastic Process | - 5153. Ancef
- (UMLS (NCI) C0700926) =Organic Chemical; Antibiotic ;
|
- 5104. Anaplastic Large Cell Lymphoma T- and Null-cell Types Refractory
- [Anaplastic large cell lymphoma resistant to treatment ( NCI )] (UMLS (NCI) C0854821) Refractory Anaplastic Large Cell Lymphoma =Neoplastic Process
| - 5154. Ancestim
- [A hematopoietic growth factor with activity on mature and immature hematopoietic progenitor cells. ( NCI )] (UMLS (NCI) C0538777) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 5105. Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology
- (UMLS (NCI) C1332283) =Neoplastic Process
| - 5155. Ancestor
- [Someone from whom you are descended (but usually more remote than a grandparent). ( NCI )] (UMLS (NCI) C0870134) Ancestors;
Progenitor =Family Group ;
|
- 5106. Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites
- [ ] (UMLS (ICD9CM) C1955709) ANAPLASTIC LYMPH XTRNDL;
=Neoplastic Process | - 5156. Anchorin CII
- [Encoded by human Annexin A5 Gene, Annexin A5 is a 35 kD 320-amino acid monomeric placental protein similar to PP4-X that contains 4 annexin repeats; some may bind calcium and phospholipid. PP4 and PP4-X (Lipocortin family) are similar to lipocortin I and calpactin I. PP4 is also an Annexin family member, Ca(2+)-dependent phospholipid binding proteins located on the plasma membrane cytosolic face. PP4 forms a voltage-dependent membrane Ca(2+) channel; key amino acids act as selectivity filters and voltage sensors, regulating pore permeability to ions. As an anticoagulant protein, PP4 acts as an indirect inhibitor of the blood coagulation cascade thromboplastin-specific complex. PP4 may bind ATRX. (OMIM, Swiss-Prot, and NCI) ( NCI )] (UMLS (NCI) C0059249) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 5107. Anaplastic Lung Carcinoma
- [A poorly differentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular or squamous differentiation. There is a male predilection. (NCI05) ( NCI )] (UMLS (NCI) C0345958) =Neoplastic Process
| - 5157. Ancid
- (UMLS (NCI) C1310603) =Pharmacologic Substance; Inorganic Chemical ;
|
- 5108. Anaplastic Malignant Neoplasm
- (UMLS (NCI) C1332287) =Neoplastic Process
| - 5158. Ancillary
- (UMLS (HL7) C1549485) =Idea or Concept =Policy type;
|
- 5109. Anaplastic Malignant Teratoma
- (UMLS (NCI) C0334521) =Neoplastic Process
| - 5159. Ancillary (filler) department is source of comment
- (UMLS (HL7) C1548190) =Idea or Concept =Source of comment;
|
- 5110. Anaplastic Oligoastrocytoma
- [Anaplastic Oligoastrocytoma is an Oligoastrocytoma with histological features of malignancy, such as increased cellularity, nuclear atypia, pleomorphism, and increased mitotic activity. (WHO) ( NCI )] (UMLS (NCI) C0431108) =Neoplastic Process
| - 5160. Ancillary Instructions
- (UMLS (HL7) C1549997) =Idea or Concept =Comment type;
|
- 5111. Anaplastic Oligodendroglioma
- [A WHO grade III oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity). ( NCI )] (UMLS (NCI) C0334590) =Neoplastic Process
| - 5161. Ancitabine hydrochloride
- [A derivative of cytarbine (ara-C). Although ancitabine's mechanism of action is unclear, it may inhibit DNA polymerase via competitive inhibition of deoxycytidine triphosphatase, resulting in inhibition of DNA replication; this agent may also incorporate into DNA and RNA. (NCI04) ( NCI )] (UMLS (NCI) C0877817) Ancytabine Hydrochloride;
CycloCMP hydrochloride;
Cyclocytidine HCL;
Cyclocytidine hydrochloride =Organic Chemical; Pharmacologic Substance |
- 5112. Anaplastic Renal Wilms Tumor
- [Wilms tumor of the kidney characterized by the presence of nuclear anaplasia. Anaplasia is defined by the presence of all of the following: multipolar polyploid mitotic figures, marked nuclear enlargement, and hyperchromasia. When anaplasia is diffuse, it is associated with an unfavorable clinical outcome. ( NCI )] (UMLS (NCI) C1332289) Anaplastic Renal Wilm's Tumor;
Anaplastic Renal Wilms' Tumor;
=Neoplastic Process | - 5162. Ancitabine Hydrochloride/Daunorubicin/Mercaptopurine/Prednisolone
- (UMLS (NCI) C0279351) =Therapeutic or Preventive Procedure
|
- 5113. Anaplastic Secondary Supratentorial Astrocytoma
- (UMLS (NCI) C1332288) Grade III Secondary Supratentorial Astrocytic Neoplasm;
Grade III Secondary Supratentorial Astrocytic Tumor;
Grade III Secondary Supratentorial Astrocytoma;
Secondary Supratentorial Anaplastic Astrocytoma;
Undifferentiated Secondary Supratentorial Astrocytoma =Neoplastic Process | - 5163. ANCYLOSTOMA BRAZILIENSE
- [ ] (UMLS (ICD9CM) C0153299) =Disease or Syndrome
|
- 5114. Anaplastic Seminoma
- (UMLS (NCI) C0334516) =Neoplastic Process
| - 5164. ANCYLOSTOMA CEYLANICUM
- [ ] (UMLS (ICD9CM) C0277120) =Disease or Syndrome
|
- 5115. Anaplastic Small Cell Carcinoma of Minor Salivary Gland
- (UMLS (NCI) C1334770) Anaplastic Small Cell Carcinoma of the Minor Salivary Gland;
Minor Salivary Gland Anaplastic Small Cell Carcinoma;
Minor Salivary Gland Neuroendocrine Carcinoma;
Minor Salivary Gland Oat Cell Carcinoma;
Neuroendocrine Carcinoma of Minor Salivary Gland;
Neuroendocrine Carcinoma of the Minor Salivary Gland;
Oat Cell Carcinoma of Minor Salivary Gland;
Oat Cell Carcinoma of the Minor Salivary Gland =Neoplastic Process ;
| - 5165. ANCYLOSTOMA DUODENALE
- (UMLS (ICD9CM) C1384687) Ancylostomiasis due to ancylostoma duodenale =Disease or Syndrome ;
|
- 5116. Anaplastic Small Cell Carcinoma of Salivary Gland
- (UMLS (NCI) C1335895) Anaplastic Small Cell Carcinoma of the Salivary Gland;
Neuroendocrine Carcinoma of Salivary Gland;
Neuroendocrine Carcinoma of the Salivary Gland;
Salivary Gland Anaplastic Small Cell Carcinoma;
Salivary Gland Neuroendocrine Carcinoma;
=Neoplastic Process ;
| - 5166. ANCYLOSTOMA NEC
- (UMLS (ICD9CM) C0546827) =Disease or Syndrome ;
|
- 5117. Anaplastic Small Cell Carcinoma of the Thyroid
- (UMLS (NCI) C0278860) =Neoplastic Process
| - 5167. Ancylostomatidae
- [ ] (UMLS (CSP) C1265425) hookworm =Invertebrate
|
- 5118. anaprilin
- [ ] (UMLS (CSP) C0700773) =Organic Chemical; Pharmacologic Substance
| - 5168. Ancylostomiasis
- [Infection of humans or animals with hookworms of the genus ANCYLOSTOMA. Characteristics include anemia, dyspepsia, eosinophilia, and abdominal swelling. ( MSH )] (UMLS (NCI) C0002831) =Disease or Syndrome
|
- 5119. Anaprox
- (UMLS (NCI) C0699095) =Organic Chemical; Pharmacologic Substance ;
| - 5169. Ancylostomiasis and necatoriasis
- [ ] (UMLS (ICD9CM) C0411279) =Disease or Syndrome
|
- 5120. anarthria
- [ ] (UMLS (CSP) C0234517) =Disease or Syndrome
| - 5170. and
- [This condition must be true. ( HL7V3.0 )] (UMLS (HL7) C1550557) =Idea or Concept =RelationshipConjunction;
|
- 5121. anasarca
- [ ] (UMLS (CSP) C0151603) =Pathologic Function
| - 5171. Andalusian
- (UMLS (HL7) C1553359) =Population Group =Spaniard;
|
- 5122. Anastomose, Failure To
- (UMLS (NCI) C0854569) Failure To Anastomose;
=Injury or Poisoning | - 5172. Andean potato mottle virus
- [ ] (UMLS (CSP) C0598201) =Virus
|
- 5123. anastomosis
- [(an-AS-ta-MO-sis) A procedure to connect healthy sections of tubular structures in the body after the diseased portion has been surgically removed. ( NCI )] (UMLS (NCI) C0677554) =Therapeutic or Preventive Procedure
| - 5173. Andriol
- (UMLS (NCI) C0592050) =Steroid; Pharmacologic Substance ;
|
- 5124. Anastomosis of gallbladder or bile duct
- [ ] (UMLS (ICD9CM) C0176902) =Therapeutic or Preventive Procedure
| - 5174. Androblastoma
- [A sex cord-stromal tumor of the testis or the ovary. It is characterized by the presence of Sertoli cells forming tubules. Leydig cells are rare or absent. It may be associated with Peutz-Jeghers syndrome. In males, the presenting symptom is a slow growing testicular mass. Most cases follow a benign clinical course. In females it may present with estrogenic or androgenic manifestations. The vast majority of cases have a benign clinical course. ( NCI )] (UMLS (NCI) C0036769) =Neoplastic Process =Neoplasms, Gonadal Tissue;
|
- 5125. Anastomosis of gallbladder to hepatic ducts
- [ ] (UMLS (ICD9CM) C0193530) =Therapeutic or Preventive Procedure
| - 5175. Androcur
- (UMLS (NCI) C0699709) =Steroid; Pharmacologic Substance ;
|
- 5126. Anastomosis of gallbladder to intestine
- [ ] (UMLS (ICD9CM) C0193544) =Therapeutic or Preventive Procedure
| - 5176. androgen
- [compounds that interact with androgen receptors in target tissues to bring about the effects similar to those of testosterone; depending on the target tissues, androgenic effects can be on sexual differentiation, male reproductive organs, spermtogenesis, secondary male sex characteristics, libido, development of muscle mass, strength, and power. ( CSP )] (UMLS (CSP) C0002844) =Pharmacologic Substance; Hormone ;
|
- 5127. Anastomosis of gallbladder to pancreas
- [ ] (UMLS (ICD9CM) C0193547) =Therapeutic or Preventive Procedure
| - 5177. androgen analog
- [steroidal compounds related to testosterone. ( CSP )] (UMLS (CSP) C0002845) =Pharmacologic Substance; Hormone ;
|
- 5128. Anastomosis of gallbladder to stomach
- [ ] (UMLS (ICD9CM) C0193546) =Therapeutic or Preventive Procedure
| - 5178. Androgen Antagonists
- [(an-tee-AN-dro-jens) Drugs used to block the production or interfere with the action of male sex hormones. ( NCI )] (UMLS (NCI) C0002842) =Pharmacologic Substance
|
- 5129. Anastomosis of hepatic duct to gastrointestinal tract
- [ ] (UMLS (ICD9CM) C0193531) =Therapeutic or Preventive Procedure
| - 5179. androgen binding protein
- [family of soluble blood carrier proteins which transport androgens from endocrines to target tissues; do not confuse with ANDROGEN RECEPTOR, which is an intracellular protein. ( CSP )] (UMLS (CSP) C0002843) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 5130. Anastomosis of kidney
- [ ] (UMLS (ICD9CM) C0177002) =Therapeutic or Preventive Procedure
| - 5180. androgen independent prostate cancer
- [ ] (UMLS (CSP) C1654637) =Neoplastic Process
|
- 5131. Anastomosis of pancreas
- (UMLS (ICD9CM) C0400505) =Therapeutic or Preventive Procedure ;
| - 5181. androgen independent prostate neoplasm
- [ ] (UMLS (CSP) C1328827) =Neoplastic Process ;
|
- 5132. Anastomosis of small intestine to rectal stump
- [ ] (UMLS (ICD9CM) C0192745) =Therapeutic or Preventive Procedure
| - 5182. Androgen insensitivity syndrome
- [A familial form of PSEUDOHERMAPHRODITISM transmitted as an X-linked recessive trait. These patients have a karyotype of 46,XY with end-organ resistance to androgen due to mutations in the androgen receptor (RECEPTORS, ANDROGEN) gene. Severity of the defect in receptor quantity or quality correlates with their phenotypes. In these genetic males, the phenotypic spectrum ranges from those with normal female external genitalia, through those with genital ambiguity as in Reifenstein Syndrome, to that of a normal male with INFERTILITY. ( MSH )] (UMLS (ICD9CM) C0039585) =Disease or Syndrome
|
- 5133. Anastrozole/Celecoxib
- (UMLS (NCI) C1328012) =Therapeutic or Preventive Procedure ;
| - 5183. Androgen Metabolism
- [Androgen Metabolism consists of diverse biochemical reactions in the adrenal cortex that produce 19-carbon steroid hormones, which promote male sexual development or convert such steroids to metabolic derivatives. ( NCI )] (UMLS (NCI) C1158330) =Molecular Function
|
- 5134. Anastrozole/Fulvestrant
- (UMLS (NCI) C1328120) =Therapeutic or Preventive Procedure; ;
| - 5184. androgen receptor
- [proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. ( CSP )] (UMLS (CSP) C0034786) =Amino Acid, Peptide, or Protein; Receptor ;
=Steroid Hormone Receptor;
|
- 5135. Anastrozole/Gefitinib
- (UMLS (NCI) C1327800) =Therapeutic or Preventive Procedure ;
| - 5185. Androgen Receptor
- [Encoded by human AR Gene (NR3 Family), the Androgen Receptor transcription factor regulates gene expression, cell proliferation, and differentiation. AR has 3 domains: N-terminal modulating (exon 1), DNA-binding (two C4 Zinc fingers, exons 2-3), and C-terminal hormone-binding (5 remaining exons). Polymorphic N-terminal poly-Gln tracts bind RAN, enhancing transactivation; decreased with increased poly-Gln length. An 87-kD (AR-A) isoform lacks a normal N-terminus, seen in the 110 kD (AR-B) form; A and B may differ in function. Ligand bound receptor translocates to the nucleus, homodimerizes, binds DNA, and stimulates transcription. Polyglutamine expansion causes Kennedy's disease. Other mutations are associated with androgen insensibility syndrome. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1447749) AR;
DHTR;
Dihydrotestosterone Receptor;
NR3C4 =Amino Acid, Peptide, or Protein; Receptor |
- 5136. Anastrozole/Trastuzumab
- (UMLS (NCI) C1134443) =Therapeutic or Preventive Procedure ;
| - 5186. Androgen Receptor (Dihydrotestosterone Receptor; Testicular Feminization; Spinal and Bulbar Muscular Atrophy; Kennedy Disease) Gene
- [This gene plays a role in the transcriptional activation of androgen responsive genes. ( NCI )] (UMLS (NCI) C1367578) Androgen Receptor Gene;
AR;
AR Gene =Gene or Genome |
- 5137. Anathana
- [ ] (UMLS (CSP) C0599386) =Mammal ;
| - 5187. Androgen Receptor-Associated Protein
- [ARA(70), encoded by proto-oncogene NCOA4, is a ligand-dependent co-activator protein that enhances specific AR transcriptional activity. The androgen receptor is a transcription factor of the steroid receptor superfamily. Although several steroid-class receptors recognize the same DNA regulatory sequence, gene-specific activation may be achieved by selective accessory factors that interact with the receptors to determine specificity of target gene activation. (from OMIM 601984 and NCI) ( NCI )] (UMLS (NCI) C1335075) Androgen Receptor-Specific Coactivator;
ARA70;
ARA70/ELE1;
ELE1;
NCOA4;
NCOA4 Protein;
Nuclear Receptor Coactivator 4;
RET Activating Protein ELE1;
RFG =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 5138. Anatidae
- [ ] (UMLS (CSP) C0999176) =Bird
| - 5188. Androgen Therapy
- (UMLS (NCI) C0279493) =Therapeutic or Preventive Procedure
|
- 5139. Anatolian Shepherd Dog
- [The Anatolian Shepherd Dog is a large dog similar to the Great Pyrenees and the Kuvasz, but more slender. The head is large and the muzzle is a bit shorter than the skull, with a blunt profile. Triangular, pendant ears are rather small with rounded tips. The back is short relative to leg length. The short or rough double coat is generally fawn with a black mask. Height: 26-30 inches (66-76 cm.) Weight: 90-150 pounds (41-68 kg.) ( NCI )] (UMLS (NCI) C1444156) =Mammal ;
| - 5189. Androgen-Induced Proliferation Inhibitor Gene
- [This gene is involved in cell cycle regulation. ( NCI )] (UMLS (NCI) C1332105) APRIN;
APRIN Gene =Gene or Genome ;
|
- 5140. Anatomic
- [Relating to anatomy. ( NCI )] (UMLS (NCI) C0002808) =Biomedical Occupation or Discipline
| - 5190. Androgen-Induced Prostate Proliferative Shutoff Associated Protein
- [Putative regulator of androgen-induced proliferative prostate cell arrest; may interact with other proteins and bind DNA; contains leucine-zipper, DNA- and ATP-binding motifs. (LocusLink) ( NCI )] (UMLS (NCI) C1332106) APRIN;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 5141. Anatomic Abnormality
- (UMLS (NCI) C0302142) =Anatomical Abnormality ;
| - 5191. ANDROGRAPHOLIDE
- (UMLS (NCI) C0051821) =Pharmacologic Substance
|
- 5142. Anatomic and physiologic measurements and manual examinations — genitourinary system
- [ ] (UMLS (ICD9CM) C0177816) =Diagnostic Procedure
| - 5192. Android
- (UMLS (NCI) C0718532) Android brand of methyltestosterone =Steroid; Pharmacologic Substance; Hormone
|
- 5143. Anatomic and physiologic measurements and manual examinations — nervous system and sense organs
- [ ] (UMLS (ICD9CM) C0177813) =Diagnostic Procedure
| - 5193. Android-F
- (UMLS (NCI) C0733925) =Steroid; Pharmacologic Substance ;
|
- 5144. Anatomic Pathology
- (UMLS (HL7) C1555812) =Intellectual Product =pathologist;
| - 5194. andromedotoxin
- [ ] (UMLS (CSP) C0061887) =Organic Chemical; Hazardous or Poisonous Substance ;
|
- 5145. Anatomic Pathology & Clinical Pathology
- (UMLS (HL7) C1555813) =Intellectual Product =pathologist;
| - 5195. Androst-5-en-17-one
- (UMLS (NCI) C0385259) =Steroid
|
- 5146. Anatomic Region
- [a general term for grouping regions of the body; preference is to use NTs. ( CSP )] (UMLS (NCI) C0005898) =Body Location or Region ;
=anatomy;
=abdomen;
back;
Extremities;
head;
pelvic;
Sholder Joint;
Body Cavity;
interstitial;
chest;
| - 5196. Androsta-1,4-diene-17-carboxylic Acid, 17-((ethoxycarbonyl)oxy)-11-hydroxy-3-oxo-, chloromethyl Ester,(11beta,17alpha)-
- [The etabonate salt form of loteprednol, an ophthalmic analog of the corticosteroid prednisolone with anti-inflammatory activity. Loteprednol etabonate exerts its effect by interacting with specific intracellular receptors and subsequently binds to DNA to modify gene expression. This results in an induction of the synthesis of certain anti-inflammatory proteins while inhibiting the synthesis of certain inflammatory mediators. Loteprednol etabonate specifically induces phospholipase A2 inhibitory proteins (collectively called lipocortins), which inhibit the release of arachidonic acid, thereby inhibiting the biosynthesis of potent mediators of inflammation, such as prostaglandins and leukotrienes. ( NCI )] (UMLS (NCI) C0126177) =Steroid; Pharmacologic Substance ;
=Androstadienes;
LOTEPREDNOL =LOTEPREDNOL ETABONATE 0.5 %;
LOTEPREDNOL ETABONATE 0.2 %;
|
- 5147. Anatomical Gift (organ donation)
- (UMLS (HL7) C1548813) =Health Care Activity =Consent Type;
| - 5197. androstane
- [any substance that is made by combining two or more elements with the 19-carbon tetracyclic hydrocarbon that is the parent structure of the androgens. ( CSP )] (UMLS (CSP) C0002854) =Steroid; Biologically Active Substance ;
|
- 5148. ANATOMICAL NARROW ANGLE
- [ ] (UMLS (ICD9CM) C0154941) =Disease or Syndrome ;
| - 5198. androstenediol
- [Unsaturated androstane derivatives which are substituted with two hydroxy groups in any position in the ring system. ( MSH )] (UMLS (CSP) C0002859) =Steroid
|
- 5149. anatomy
- [tree section heading for anatomical, physiological, and related terms. ( CSP )] (UMLS (CSP) C0700276) =Anatomical Structure ;
=CRISP Thesaurus;
=body fluid;
Anatomic Region;
Body System, Cardiovascular;
Body System, Gastrointestinal;
Body System, Endocrine/Metabolic;
allergic/immunologic body system;
Body System, Hepatic;
musculoskeletal system;
Body System, Neurologic;
Body System, Pulmonary;
Normal Tissue;
urinary tract;
morphology;
Integument;
Reproductive System | - 5199. Androstenedione Aromatase Inhibitor
- [An agent that blocks the function of the enzyme aromatase with antineoplastic activity. Aromatase inhibitors belong to two classes: Type I steroidal drugs are androgen substrate analogues that bind competitively but irreversibly to the enzyme. Type II nonsteroidal inhibitors fit into the substrate binding site and bind reversibly to the enzyme. Present in many tissues, aromatases are heme-containing enzymes that catalyze the adrenal conversion of cholesterol to pregnenolone and the peripheral conversion (aromatization) of androgenic precursors to estrogens. (NCI04) ( NCI )] (UMLS (NCI) C0593802) =Pharmacologic Substance ;
=enzyme inhibitor;
|
- 5150. anatomy of plant
- [ ] (UMLS (CSP) C0599143) =Organism Attribute
| - 5200. androsterone
- [A steroid metabolite derived from sex hormones, which displays weak androgenic properties. In testes is formed from progesterone. Androsterone sulfate is clinically recognized as one of the major androgen metabolites found in urine, in males and females. It is made in the liver from the metabolism of testosterone. Androsterone glucuronide, a dihydrotestosterone metabolite, is present in serum. Androsterone is a weak anabolic hormone. (NCI04) ( NCI )] (UMLS (CSP) C0002865) =Steroid; Hormone ;
|
home 
Armenian-English 
top